BerGenBio ASA Implements Employee Share Options

BerGenBio ASA (BRRGD) has released an update.

BerGenBio ASA, a biopharmaceutical company, has implemented a share option program granting 1,315,000 options to employees, in line with a strategy to attract and retain talent. These options, which represent 3.3% of the company’s total issued shares, vest over three years and are exercisable at a strike price of NOK 11.226. Key executives, including the CEO and CFO, have received significant portions of these options as part of their compensation package.

For further insights into BRRGD stock, check out TipRanks’ Stock Analysis page.